|
The ornamental design for a tablet, as shown and described. |
FIG. 1 is a top plan view of a tablet showing our new design;
FIG. 2 is a bottom plan view thereof;
FIG. 3 is a front elevational view thereof;
FIG. 4 is a rear elevational view thereof;
FIG. 5 is a left side elevational view thereof;
FIG. 6 is a right side elevational view thereof;
FIG. 7 is a top perspective view thereof, on an enlarged scale; and,
FIG. 8 is a bottom perspective view thereof, on an enlarged scale.
Katdare, Ashok V., Chen, Tzyy-Show H., Nyairo, Thomas G.
Patent | Priority | Assignee | Title |
D564086, | May 30 2005 | Takeda Nycomed AS | Tablet |
D671636, | Apr 23 2010 | DAIICHI SANKYO COMPANY, LIMITED | Pharmaceutical tablet |
D741990, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
D755949, | Jul 30 2013 | RB HEALTH US LLC | Tablet |
D787042, | Apr 28 2015 | Celgene Corporation | Pharmaceutical tablet |
D787043, | Jun 23 2015 | Celgene Corporation | Pharmaceutical tablet |
D813372, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D835257, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D835258, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D858741, | Feb 22 2017 | Celgene Corporation | Pharmaceutical tablet |
D947358, | Mar 19 2019 | Novo Nordisk A/S | Pill |
Patent | Priority | Assignee | Title |
2687367, | |||
4693886, | Apr 22 1985 | ALZA Corporation | Osmotic device with inert core |
4851228, | Jun 20 1984 | MERCK & CO , INC , A CORP OF NJ | Multiparticulate controlled porosity osmotic |
5424074, | Jun 20 1989 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition for potassium supplementation |
5427798, | Aug 14 1992 | SMITHKLINE BEECHAM CORPORATION, A PENNSYLVANIA CORPORATION | Controlled sustained release tablets containing bupropion |
5512299, | Mar 30 1992 | ALZA Corporation | Method of treating oral inflammatory disease |
5770225, | Apr 28 1989 | McNeil-PPC, Inc. | Process of preparing a subcoated simulated capsule-like medicament |
5824338, | Aug 19 1996 | L. PERRIGO COMPANY | Caplet and gelatin covering therefor |
216307, | |||
D258091, | Aug 31 1978 | Marion Laboratories, Inc. | Pharmaceutical tablet |
D301764, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
D302051, | Dec 21 1987 | RHONE-POULENC RORER PHARMACEUTICALS INC | Pharmaceutical tablet |
D316914, | Aug 01 1989 | MERRELL DOW PHARMACEUTICALS LTD | Tablet |
D359554, | Dec 02 1991 | The Procter & Gamble Company | Tablet |
D375157, | Dec 22 1992 | Merck Sharp & Dohme Corp | Tablet |
D379223, | Sep 13 1995 | Merck Sharp & Dohme Corp | Pharmaceutical tablet |
D380825, | Oct 31 1994 | Merck Sharp & Dohme Corp | Pharmaceutical tablet |
D400672, | Mar 21 1996 | Merck Sharp & Dohme Corp | Pharmaceutical tablet |
D403396, | Nov 28 1996 | Astra Aktiebolag | Tablet |
56478, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Apr 16 1999 | Merck & Co., Inc. | (assignment on the face of the patent) | / | |||
Sep 08 1999 | KATDARE, ASHOK V | MERCK & CO , INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 010634 | /0261 | |
Sep 10 1999 | CHEN, TZYY-SHOW H | MERCK & CO , INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 010634 | /0276 | |
Sep 10 1999 | NYAIRO, THOMAS G | MERCK & CO , INC | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 010634 | /0276 | |
Nov 02 2009 | MERCK & CO , INC | Merck Sharp & Dohme Corp | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 023870 | /0001 | |
Apr 26 2012 | Merck Sharp & Dohme Corp | Schering Corporation | MERGER SEE DOCUMENT FOR DETAILS | 028850 | /0515 | |
May 02 2012 | Schering Corporation | Merck Sharp & Dohme Corp | CHANGE OF NAME SEE DOCUMENT FOR DETAILS | 028866 | /0511 |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |